In this episode, Dr. Borjan and Dr. Whitby discuss a wide range of treatment options for COVID-19, and what we currently know based on available studies. Discussion includes therapies with proposed antiviral activity, use of convalescent plasma, and agents being used to address cytokine storm. They also touch on use of anticoagulants, nutritional support, and other supportive care measures.
Jovan Borjan, PharmD, BCIDP is the Clinical Pharmacy Specialist in Infectious Diseases at University of Texas MD Anderson Cancer Center in Houston, Texas
Hosted by: Dale Whitby, PharmD, Editor-in-Chief of Drug Information, Elsevier